Literature DB >> 34521999

Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Alexander J M Dingemans1, Kim M G Truijen1, Jung-Hyun Kim2, Zahide Alaçam3, Laurence Faivre4, Kathleen M Collins5, Erica H Gerkes6, Mieke van Haelst7, Ingrid M B H van de Laar8, Kristin Lindstrom9, Mathilde Nizon10, James Pauling11, Edyta Heropolitańska-Pliszka12, Astrid S Plomp13, Caroline Racine4, Rani Sachdev14, Margje Sinnema15, Jon Skranes16, Hermine E Veenstra-Knol6, Eline A Verberne7, Anneke T Vulto-van Silfhout1, Marlon E F Wilsterman17, Eun-Young Erin Ahn18,19, Bert B A de Vries20, Lisenka E L M Vissers21.   

Abstract

Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.
© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34521999      PMCID: PMC8904542          DOI: 10.1038/s41431-021-00960-4

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  25 in total

1.  A de novo paradigm for mental retardation.

Authors:  Lisenka E L M Vissers; Joep de Ligt; Christian Gilissen; Irene Janssen; Marloes Steehouwer; Petra de Vries; Bart van Lier; Peer Arts; Nienke Wieskamp; Marisol del Rosario; Bregje W M van Bon; Alexander Hoischen; Bert B A de Vries; Han G Brunner; Joris A Veltman
Journal:  Nat Genet       Date:  2010-11-14       Impact factor: 38.330

2.  Diagnostic exome sequencing in persons with severe intellectual disability.

Authors:  Joep de Ligt; Marjolein H Willemsen; Bregje W M van Bon; Tjitske Kleefstra; Helger G Yntema; Thessa Kroes; Anneke T Vulto-van Silfhout; David A Koolen; Petra de Vries; Christian Gilissen; Marisol del Rosario; Alexander Hoischen; Hans Scheffer; Bert B A de Vries; Han G Brunner; Joris A Veltman; Lisenka E L M Vissers
Journal:  N Engl J Med       Date:  2012-10-03       Impact factor: 91.245

3.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.

Authors:  Peter N Robinson; Sebastian Köhler; Sebastian Bauer; Dominik Seelow; Denise Horn; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2008-10-23       Impact factor: 11.025

4.  Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots.

Authors:  Celine Chiu; Stefanie Loth; Michaela Kuhlen; Sebastian Ginzel; Jörg Schaper; Thorsten Rosenbaum; Torsten Pietsch; Arndt Borkhardt; Jessica I Hoell
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

5.  Son maintains accurate splicing for a subset of human pre-mRNAs.

Authors:  Alok Sharma; Michael Markey; Keshia Torres-Muñoz; Sapna Varia; Madhavi Kadakia; Athanasios Bubulya; Paula A Bubulya
Journal:  J Cell Sci       Date:  2011-12-22       Impact factor: 5.285

6.  Quantitative facial phenotyping for Koolen-de Vries and 22q11.2 deletion syndrome.

Authors:  Alexander J M Dingemans; Diante E Stremmelaar; Roos van der Donk; Lisenka E L M Vissers; David A Koolen; Patrick Rump; Jayne Y Hehir-Kwa; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2021-02-18       Impact factor: 5.351

7.  Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.

Authors:  Xiaolin Zhu; Slavé Petrovski; Pingxing Xie; Elizabeth K Ruzzo; Yi-Fan Lu; K Melodi McSweeney; Bruria Ben-Zeev; Andreea Nissenkorn; Yair Anikster; Danit Oz-Levi; Ryan S Dhindsa; Yuki Hitomi; Kelly Schoch; Rebecca C Spillmann; Gali Heimer; Dina Marek-Yagel; Michal Tzadok; Yujun Han; Gordon Worley; Jennifer Goldstein; Yong-Hui Jiang; Doron Lancet; Elon Pras; Vandana Shashi; Duncan McHale; Anna C Need; David B Goldstein
Journal:  Genet Med       Date:  2015-01-15       Impact factor: 8.822

8.  Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities.

Authors:  Masashi Ueda; Tohru Matsuki; Masahide Fukada; Shima Eda; Akie Toya; Akio Iio; Hidenori Tabata; Atsuo Nakayama
Journal:  Mol Brain       Date:  2020-05-24       Impact factor: 4.041

Review 9.  Clinical and genetic analysis of ZTTK syndrome caused by SON heterozygous mutation c.394C>T.

Authors:  Yu Yang; Lei Xu; Zhen Yu; Hui Huang; Li Yang
Journal:  Mol Genet Genomic Med       Date:  2019-09-26       Impact factor: 2.183

10.  A novel frameshift variant in SON causes Zhu-Tokita-Takenouchi-Kim Syndrome.

Authors:  Ya Tan; Ling Duan; Kai Yang; Qian Liu; Jing Wang; Zhe Dong; Zhi Li; Yiwen He; Yousheng Yan; Li Lin
Journal:  J Clin Lab Anal       Date:  2020-04-14       Impact factor: 2.352

View more
  3 in total

1.  Good genotype-phenotype relationships in rare disease are hard to find.

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2022-03       Impact factor: 4.246

2.  Commentary on: Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Authors:  Elizabeth Emma Palmer
Journal:  Eur J Hum Genet       Date:  2021-11-29       Impact factor: 4.246

3.  Anesthesia of the Patient with Zhu-Tokita-Takenouchi-Kim (ZTTK) Syndrome: A Case Report.

Authors:  Jan Hudec; Martina Kosinova
Journal:  Children (Basel)       Date:  2022-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.